Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion
Open Access
- 16 June 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hepatology
- Vol. 52 (3), 945-953
- https://doi.org/10.1002/hep.23748
Abstract
Epithelial‐to‐mesenchymal transition (EMT) is predicted to play a critical role in metastatic disease in hepatocellular carcinoma. In this study, we used a novel murine model of EMT to elucidate a mechanism of tumor progression and metastasis. A total of 2 × 106 liver cells isolated from Ptenloxp/loxp/Alb‐Cre+ mice, expanded from a single CD133+CD45− cell clone, passage 0 (P0), were sequentially transplanted to obtain two passages of tumor cells, P1 and P2. Cells were analyzed for gene expression using microarray and real‐time polymerase chain reaction. Functional analysis included cell proliferation, migration, and invasion in vitro and orthotopic tumor metastasis assays in vivo. Although P0, P1, and P2 each formed tumors consistent with mixed liver epithelium, within the P2 cells, two distinct cell types were clearly visible: cells with epithelial morphology similar to P0 cells and cells with fibroblastoid morphology. These P2 mesenchymal cells demonstrated increased locomotion on wound healing; increased cell invasion on Matrigel basement membrane; increased EMT‐associated gene expression of Snail1, Zeb1, and Zeb2; and down‐regulated E‐cadherin. P2 mesenchymal cells demonstrated significantly faster tumor growth in vivo compared with P2 epithelial counterparts, with invasion of intestine, pancreas, spleen, and lymph nodes. Furthermore, P2 mesenchymal cells secreted high levels of hepatocyte growth factor (HGF), which we propose acts in a paracrine fashion to drive epithelial cells to undergo EMT. In addition, a second murine liver cancer stem cell line with methionine adenosyltransferase 1a deficiency acquired EMT after sequential transplantations, indicating that EMT was not restricted to Pten‐deleted tumors. Conclusion: EMT is associated with a high rate of liver tumor proliferation, invasion, and metastasis in vivo, which is driven by HGF secreted from mesenchymal tumor cells in a feed‐forward mechanism. (HEPATOLOGY 2010)Keywords
This publication has 38 references indexed in Scilit:
- Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-βJournal of Hepatology, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Twist expression promotes migration and invasion in hepatocellular carcinomaBMC Cancer, 2009
- The basics of epithelial-mesenchymal transitionJCI Insight, 2009
- Epithelial-mesenchymal transitions: the importance of changing cell state in development and diseaseJCI Insight, 2009
- Biomarkers for epithelial-mesenchymal transitionsJCI Insight, 2009
- CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-β-induced apoptosisJournal of Hepatology, 2008
- SALL4 is a key regulator of survival and apoptosis in human leukemic cellsBlood, 2008
- Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient miceJournal of Hepatology, 2007
- Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of SnailThe EMBO Journal, 2006